The activation marker CD69 in T cells is reduced in HNSCC patients, and T-helper (CD4+) and cytotoxic T lymphocyte (CD8+) sub-populations have been found to be decreased in their peripheral blood [11]. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.